Sosei Heptares (the corporate brand of Sosei Group Corporation) is a research-focused biotechnology group, publicly listed in Japan (TSE: 4565) and with sites in Tokyo, London and Cambridge (UK).
Our mission is to make a significant contribution to improving the quality of life and health of people around the world. To achieve this, we will discover, design and develop the most innovative and effective medicines for patients worldwide, through our world-leading patent-protected StaR® technology and platform.
Our primary focus is the discovery and early development of new medicines originating from our proprietary G Protein-Coupled Receptor (GPCR)-targeted StaR® technology and Structure-Based Drug Design (SBDD) platform capabilities. We are advancing a broad and deep pipeline of novel medicines across multiple therapeutic areas, including CNS, immuno-oncology, gastroenterology, inflammation and other rare/specialty indications.
We have established partnerships with some of the world’s leading pharmaceutical companies, including Abbvie, AstraZeneca, Genentech (Roche), Novartis, Pfizer and Takeda; and additionally, with multiple emerging biotechnology companies.
Sosei Heptares has approximately 177 employees based at its new R&D research facility at Granta Park. The size of the company ensures a transparent linkage between all activities from early discovery through to clinical development.
We are currently seeking a molecular biologist (Scientist grade) to join the Protein Engineering group working on GPCR structure determination to enable drug discovery efforts. This is an exceptional opportunity to participate in pioneering science with an Industry-leading Drug Discovery company.
The successful candidate will be expected to work independently, and the role will include the following responsibilities
Our preferred candidate will have the following profile:
Applicants must be able to demonstrate proof of the right to work in the United Kingdom.
We offer a competitive salary and benefits package commensurate with qualifications and experience.
Heptares is an equal opportunities employer.
Applications should include a covering letter, providing a short description of the background to their interest in the role, with curriculum vitae including the names and contact details for two referees. Please apply through our on-line jobs’ portal with your application in pdf format, quoting reference number 2021-2PE. The closing date for applications is 31 May 2021.
Sosei Heptares does not accept speculative or unsolicited CVs from agencies. All speculative or unsolicited CVs submitted without an agreement in place will be considered Sosei Heptare’ss property and will not obligate us to pay a referral fee.